In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018 | Zendy

Robert K. Flamm | Zendy; Dee Shortridge | Zendy; Mariana Castanheira | Zendy; Hélio S. Sader | Zendy; Michael A. Pfaller | Zendy

Open Access

In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018

Author(s) -

Robert K. Flamm,

Dee Shortridge,

Mariana Castanheira,

Hélio S. Sader,

Michael A. Pfaller

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01154-19

Subject(s) - stenotrophomonas maltophilia , microbiology and biotechnology , acinetobacter baumannii , acinetobacter calcoaceticus , acinetobacter , colistin , biology , trimethoprim , minocycline , burkholderia , sulfamethoxazole , burkholderia cepacia complex , ciprofloxacin , pseudomonas aeruginosa , antimicrobial , antibiotics , bacteria , genetics

We evaluated the activity of minocycline and comparator agents against a large number ofStenotrophomonas maltophilia (n = 1,289),Acinetobacter baumannii -Acinetobacter calcoaceticus species complex (n = 1,081), andBurkholderia cepacia complex (n = 101) isolates collected from 2014 to 2018 from 87 U.S. medical centers spanning all 9 census divisions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research